Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

2.70
-0.2000-6.90%
Post-market: 2.700.00000.00%19:12 EDT
Volume:31.45K
Turnover:88.11K
Market Cap:11.45M
PE:-0.32
High:2.87
Open:2.87
Low:2.70
Close:2.90
52wk High:20.59
52wk Low:2.45
Shares:4.24M
Float Shares:4.06M
Volume Ratio:1.15
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3544
EPS(LYR):-8.3544
ROE:-170.27%
ROA:-71.01%
PB:1.43
PE(LYR):-0.32

Loading ...

May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Oct 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]